Results indicate a need for providers to ask depressed patients about their marijuana use.
A rise in overdose deaths is associated with overprescribing of opioid analgesic medications.
Fewer people believe marijuana is harmful.
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive chemical ingredient in cannabis.
The report also sheds light on the most significant predictors of substance abuse.
The increased use of synthetic cannabinoids presents a serious public health threat.
Alterations in reward processing may increase users' risk of continued drug use and subsequent addiction.
Chronic and severe cannabis-dependence is associated with deficits in striatal dopamine release.
Marijuana use is associated with development of various neuropsychiatric conditions such as schizophrenia, anxiety, and depression.
Tetrahydrocannabinol (THC) is the main active chemical ingredient found in cannabis and is a potent cannabinoid receptor (CB)-1 agonist.
Prolonged cannabis use is a risk factor for periodontal disease.
Study links heavy cannabis use in male teens to increased mortality by age 60.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression